The phosphodiesterase-5 inhibitor sildenafil reduces neuroinflammation in hippocampus and improves cognitive performance in APP/PS1 transgenic mice model of Alzheimer’s disease [15]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.